Free Trial

Lumentum (NASDAQ:LITE) Trading Down 5.1% - What's Next?

Lumentum logo with Computer and Technology background
Image from MarketBeat Media, LLC.

Key Points

  • Shares fell 5.1% after Q3 results that delivered an EPS beat of $2.37 and ~90% Y/Y revenue growth but a slight revenue miss ($808.4M vs. $810.05M); management set Q4 EPS guidance of 2.85–3.05 above consensus.
  • Analysts raised price targets sharply (BNP Paribas and Rosenblatt to $1,300; UBS to $960) and the consensus target is about $996, signaling strong bullish conviction in Lumentum’s AI/data‑center opportunity despite concerns about execution and potential “AI bottlenecks.”
  • Insiders have been sellers, with roughly 65,775 shares sold (~$38.9M) in the last three months, a factor that, combined with the revenue miss, fueled near‑term profit‑taking.
  • MarketBeat previews the top five stocks to own by June 1st.

Lumentum Holdings Inc. (NASDAQ:LITE - Get Free Report) shares fell 5.1% during trading on Wednesday . The company traded as low as $902.01 and last traded at $944.28. 9,763,165 shares were traded during trading, an increase of 64% from the average session volume of 5,949,904 shares. The stock had previously closed at $994.56.

Lumentum News Roundup

Here are the key news stories impacting Lumentum this week:

  • Positive Sentiment: Analysts pushed price targets sharply higher across the street (BNP Paribas, JPMorgan, Rosenblatt, Stifel, Loop Capital, Barclays), signaling stronger long‑term conviction tied to Lumentum’s AI/data‑center opportunity; these upgrades support upside momentum. BNP Paribas raises PT
  • Positive Sentiment: Operational beat and stronger guidance: Q3 EPS of $2.37 topped estimates and management set Q4 EPS guidance (2.85–3.05) above consensus, while revenue rose ~90% Y/Y — fundamentals that underpin the bullish analyst moves. Q3 results and outlook
  • Neutral Sentiment: Earnings / conference call materials and transcripts are available for deeper reading; management reiterated forward‑looking assumptions and the usual disclaimer about forward‑looking statements, useful for modeling but not new guidance. Earnings transcript
  • Negative Sentiment: Near‑term market reaction was negative: shares fell after the print as investors parsed a revenue miss vs. street expectations and some traders booked gains after a multi‑session run. This tug‑of‑war between strong EPS/guide and revenue shortfalls pressured the stock. Market reaction Narrative shift / Yahoo
  • Negative Sentiment: Analyst caution on execution / AI bottlenecks: commentary (e.g., Seeking Alpha) highlights potential supply/production or “AI bottleneck” risks that could constrain fulfillment of surging demand — a factor that could damp investor enthusiasm until clarity on capacity and timing is confirmed. AI bottleneck analysis

Wall Street Analysts Forecast Growth

A number of brokerages have commented on LITE. UBS Group boosted their price objective on Lumentum from $455.00 to $960.00 and gave the stock a "neutral" rating in a report on Wednesday. BNP Paribas Exane boosted their price objective on Lumentum from $1,040.00 to $1,300.00 in a report on Wednesday. B. Riley Financial reissued a "buy" rating on shares of Lumentum in a report on Friday, May 1st. Rosenblatt Securities boosted their price objective on Lumentum from $900.00 to $1,300.00 and gave the stock a "buy" rating in a report on Wednesday. Finally, Northland Securities set a $1,000.00 price objective on Lumentum in a report on Monday, April 20th. Thirteen analysts have rated the stock with a Buy rating and seven have issued a Hold rating to the company. According to data from MarketBeat.com, the stock has an average rating of "Moderate Buy" and a consensus target price of $996.05.

Check Out Our Latest Stock Report on LITE

Lumentum Trading Down 5.1%

The company has a market capitalization of $67.42 billion, a P/E ratio of 289.66 and a beta of 1.53. The company has a debt-to-equity ratio of 0.06, a current ratio of 0.61 and a quick ratio of 0.45. The firm has a fifty day moving average price of $766.66 and a 200-day moving average price of $492.31.

Lumentum (NASDAQ:LITE - Get Free Report) last released its earnings results on Tuesday, May 5th. The technology company reported $2.37 earnings per share (EPS) for the quarter, beating the consensus estimate of $2.27 by $0.10. The company had revenue of $808.40 million during the quarter, compared to analyst estimates of $810.05 million. Lumentum had a return on equity of 17.27% and a net margin of 11.95%.Lumentum's quarterly revenue was up 90.1% on a year-over-year basis. During the same period in the prior year, the company posted $0.57 earnings per share. Lumentum has set its Q4 2026 guidance at 2.850-3.050 EPS. On average, equities research analysts anticipate that Lumentum Holdings Inc. will post 5.87 earnings per share for the current year.

Insiders Place Their Bets

In other news, Director Penny Herscher sold 4,849 shares of the company's stock in a transaction that occurred on Friday, February 6th. The stock was sold at an average price of $535.48, for a total value of $2,596,542.52. Following the completion of the transaction, the director directly owned 6,057 shares of the company's stock, valued at $3,243,402.36. This represents a 44.46% decrease in their ownership of the stock. The transaction was disclosed in a legal filing with the SEC, which is available at this hyperlink. Also, CFO Wajid Ali sold 5,302 shares of the company's stock in a transaction that occurred on Friday, February 27th. The shares were sold at an average price of $691.13, for a total value of $3,664,371.26. Following the completion of the transaction, the chief financial officer directly owned 66,287 shares of the company's stock, valued at approximately $45,812,934.31. This represents a 7.41% decrease in their ownership of the stock. The disclosure for this sale is available in the SEC filing. In the last three months, insiders sold 65,775 shares of company stock valued at $38,851,343. Insiders own 0.43% of the company's stock.

Hedge Funds Weigh In On Lumentum

Institutional investors and hedge funds have recently bought and sold shares of the company. Hilton Head Capital Partners LLC bought a new position in Lumentum during the first quarter valued at $25,000. Sachetta LLC grew its holdings in Lumentum by 118.8% during the first quarter. Sachetta LLC now owns 35 shares of the technology company's stock valued at $25,000 after purchasing an additional 19 shares during the period. EverSource Wealth Advisors LLC grew its holdings in Lumentum by 363.9% during the third quarter. EverSource Wealth Advisors LLC now owns 167 shares of the technology company's stock valued at $27,000 after purchasing an additional 131 shares during the period. V Square Quantitative Management LLC bought a new position in Lumentum during the fourth quarter valued at $28,000. Finally, Truvestments Capital LLC grew its holdings in Lumentum by 300.0% during the fourth quarter. Truvestments Capital LLC now owns 76 shares of the technology company's stock valued at $28,000 after purchasing an additional 57 shares during the period. 94.05% of the stock is owned by institutional investors.

About Lumentum

(Get Free Report)

Lumentum Holdings Inc, headquartered in San Jose, California, is a leading provider of photonic technologies that enable high-speed optical communication networks and advanced industrial applications. The company designs and manufactures a broad range of lasers, optical modules and subsystems tailored to the evolving requirements of telecommunications carriers, cloud data centers and enterprise networking.

Its core product portfolio includes tunable and fixed-wavelength laser transmitters, coherent optical engines, transceivers for long-haul, metro and data center interconnects, as well as test and measurement instruments.

Featured Articles

This instant news alert was generated by narrative science technology and financial data from MarketBeat in order to provide readers with the fastest reporting and unbiased coverage. Please send any questions or comments about this story to contact@marketbeat.com.

Should You Invest $1,000 in Lumentum Right Now?

Before you consider Lumentum, you'll want to hear this.

MarketBeat keeps track of Wall Street's top-rated and best performing research analysts and the stocks they recommend to their clients on a daily basis. MarketBeat has identified the five stocks that top analysts are quietly whispering to their clients to buy now before the broader market catches on... and Lumentum wasn't on the list.

While Lumentum currently has a Moderate Buy rating among analysts, top-rated analysts believe these five stocks are better buys.

View The Five Stocks Here

Reduce the Risk Cover

Market downturns give many investors pause, and for good reason. Wondering how to offset this risk? Click the link to learn more about using beta to protect your portfolio.

Get This Free Report
Like this article? Share it with a colleague.

Featured Articles and Offers

Recent Videos

Stock Lists

All Stock Lists

Investing Tools

Calendars and Tools

Search Headlines